Latest Women's Healthcare Insights

Boston, MA -- October 12: Women's HealthX is pleased to welcome Orrick as a sponsor for this year's event in Boston.

Boston MA -- October 14: Women's HealthX is pleased to announce that Dr. Emily Von Bargen, Urogynecologist and Gynecologic Surgeon at Mass General Brigham, will lead a specialized clinical session at this year's summit at Encore Boston Harbor. As health systems strive to improve outcomes and address historically stigmatized or overlooked areas of care, clinical leadership that drives specialized, evidence-based interventions is vital.

Boston MA -- October 9: The era of siloed healthcare apps is rapidly coming to an end as enterprise buyers demand unified systems of care.

Boston, MA -- October 12: Women's HealthX has officially confirmed that Susan Gilbert, Co-Director of the National Coalition for Sexual Health (NCSH), will co-chair the Sexual Health & Wellness track alongside NCSH Program Director Megan Higdon.

Boston MA -- October 28: Life sciences teams are designing clinical trials solely to achieve regulatory endpoints, only to face massive rejection from commercial payers.

Boston, MA -- October 8: Women's HealthX is pleased to welcome OBHG (OB Hospitalist Group) as a Silver Sponsor for this year's event in Boston.

Boston, MA -- October 8: Women's HealthX is pleased to welcome Progyny as an Exhibitor for this year's event in Boston.

Boston MA -- October 9: Women control 80% of household healthcare buying decisions, yet provider organizations are severely mismanaging this commercial opportunity.

Boston, MA -- October 8: Women's HealthX is pleased to welcome 3 Daughters Health as a Start-Up Partner for this year's event in Boston.

Boston MA -- October 28: A severe temporal disconnect is paralyzing commercial adoption across the U.S. healthcare system....

Boston, MA -- October 8: Women's HealthX is pleased to welcome Beacon Biosignals as a Silver Sponsor for this year's event in Boston.

Boston, MA -- October 8: Women's HealthX is pleased to welcome Sword Health as an Exhibitor for this year's event in Boston.

Boston, MA -- October 8: Women's HealthX is pleased to welcome UltrasoundAI as a Silver Sponsor for this year's event in Boston.

Boston, MA — October 10: Women's HealthX is pleased to announce that Dr. Jatin Dave, Chief Medical Officer of Government Products at UPMC Health Plan, will anchor a keynote panel at this year's summit at Encore Boston Harbor.

Boston, MA — October 10: Women's HealthX is pleased to announce that Dr. Robyn Faye, Co-Director of the Jefferson Menopause Program and Gynecologist at Jefferson Health, will join the speaking faculty for this year's summit at Encore Boston Harbor.

Boston MA -- October 27: New therapeutics and maternal-fetal diagnostics are being developed faster than payer utilization management protocols can adapt.

Boston MA -- October 14: Frontline healthcare providers are urgently signaling that the industry's focus must broaden beyond traditional reproductive timelines.

Boston MA -- October 8: Frontline obstetricians are increasingly trapped between evolving standards of care and antiquated utilization management protocols.

Boston MA -- October 12: Corporate benefits leaders are rapidly broadening their focus beyond family-building and parental support...

Boston MA -- October 8: Maternity care continues to command the highest level of focus from corporate leadership and CHROs.

Boston MA -- October 8: Women's health is no longer simply a benefits conversation; it is a core talent retention and productivity strategy.

Boston MA -- October 13: Economic value is increasingly central to commercialization efforts, significantly outpacing traditional clinical trial outcomes in the eyes of commercial payers.

Boston MA -- October 7: While investment continues across a broad range of conditions, fertility remains a major area of focus for product development, investment, and innovation activity.

Boston MA -- October 12: While the broader healthcare industry obsesses over artificial intelligence, health system leaders are aggressively prioritizing a much more fundamental challenge: basic patient access.

Boston MA -- October 7: Despite significant advances in women's health innovation, biopharma organizations are struggling to translate clinical success into commercial adoption.

Boston MA -- October 6: Health systems are successfully building the front door to women's healthcare, but they are completely failing to capture the lifetime value of those patients.

Boston MA -- October 6: For decades, commercial investment in women's health was almost exclusively synonymous with maternal and fertility care. That era is officially over.

Boston MA -- October 6: As the women's health market continues to mature, health plans are demanding measurable economic value before scaling coverage for new delivery models.

Boston, MA -- October 5 2026: Women's HealthX is pleased to announce that Amba Kasongo, healthcare strategist, board advisor, and women's health equity advocate, will serve as Chairperson for this year's summit at Encore Boston Harbor.

Boston MA, Sept. 22: Despite a surge in awareness and investment surrounding women's health, a new cross-sector report reveals that fragmented clinical pathways, underdeveloped foundational biology, and rigid payer frameworks are creating massive bottlenecks. All of which are delaying patient care by years and stalling the commercialization of novel therapeutics.

Boston MA -- September 28: As clinical guidance for longitudinal female care rapidly evolves, hospital operations are lagging behind. The Women's Health Infrastructure Report 2026 indicates a growing gap between emerging models of care and the infrastructure built to support them.

Boston MA -- September 22: For frontline clinicians, the bottleneck in women's healthcare is no longer a lack of medical innovation. According to the Women's Health Infrastructure Report 2026, providers find themselves increasingly trapped between evolving standards of care and antiquated utilization management.

Boston MA -- September 28: There is a severe temporal disconnect paralyzing adoption in employer-sponsored health plans. The Women's Health Infrastructure Report 2026 reveals that employers expect rapid economic returns that fundamentally clash with the multi-year timelines required by payers.

Boston MA -- September 21: Women's health is no longer just a benefits conversation; it is a core talent retention strategy. However, the Women's Health Infrastructure Report 2026 highlights a severe measurement gap between executive priorities and actual tracking.

Boston MA -- September 28: The FDA's Diversity Action Plan mandates have fundamentally shifted clinical operations. Data from the Women's Health Infrastructure Report 2026 indicates that sponsors can no longer treat demographic representation as a retrospective goal.

Boston MA -- September 22: The life sciences sector is caught in a vice between tightening federal trial requirements and hostile commercial payer environments. The Women's Health Infrastructure Report 2026 reveals that while clinical innovation is accelerating, translating that success into market adoption remains a massive operational barrier.

Boston MA -- September 28: Women's health is no longer being viewed solely through a clinical lens. Data from the Women's Health Infrastructure Report 2026 confirms that provider organizations are increasingly recognizing it as a strategic growth opportunity to attract patients and strengthen organizational performance.

Boston MA -- September 22: Health systems are navigating a complex operational paradox. According to the Women's Health Infrastructure Report 2026, while women's health is viewed as a critical growth driver, the infrastructure required to deliver it is under severe financial strain.

Boston MA -- September 22: Maternal health has historically focused heavily on physical outcomes. But according to contributors to the Women's Health Infrastructure Report 2026, payers are actively shifting their focus toward mental health to control downstream costs.

Boston, MA -- September 18 2026: Women's HealthX is pleased to announce that Beth Quinn, Senior Director, Women's Health Operations at UPMC, has officially joined the speaker faculty for this year's summit at Encore Boston Harbor.

Boston, MA -- September 18 2026: Maternal mortality and morbidity are often examined through the catastrophic events that occur at the end of a patient's pregnancy or hospital stay. However, according to Dr. Kate Arnold, Program Manager at ARPA-H, healthcare leaders must look further upstream at the smaller clinical decisions that can increase a patient's risk throughout pregnancy, labor and delivery.

Boston, MA -- September 18 2026: For many people living with endometriosis, treatment options remain centered on hormonal therapies, pain medication and surgery. Hormonal therapies help many women, but their effectiveness may be incomplete or temporary.

Boston, MA -- September 17 2026: Women's HealthX is pleased to announce that Dr. Kavita Shah Arora, Professor and Division Director for General Obstetrics, Gynecology, and Midwifery at the University of North Carolina at Chapel Hill, has officially joined the speaker faculty for this year's summit at Encore Boston Harbor.

Boston, MA -- September 11 2026: Women's HealthX is pleased to welcome Realize-365 as a Start-Up Partner for this year's event in Boston! As healthcare organizations continue to face growing administrative complexity, fragmented records and increasing pressure to improve outcomes...

Boston MA -- September 21: Women's health has never had more attention. But according to contributors to the Women's Health Infrastructure Report 2026, attention alone isn't enough.

Boston, MA -- September 10 2026: Women's HealthX is pleased to welcome Labcorp as a Silver Sponsor for this year's event in Boston. As healthcare organizations continue to focus...

Boston, MA -- September 16 2026: Women's HealthX has officially confirmed the addition of Dr Karina Hoan, Medical Director of Surgical Specialties at The Portland Clinic, to the marquee Day 1 panel faculty at the Encore Boston Harbor.

Boston, MA -- September 15 2026: Women's HealthX is pleased to announce that Sarah Kleinpeter, Senior Vice President of the Global Alzheimer's Disease and Dementia Franchise at Biogen, has officially joined the speaker faculty for this year's summit at the Encore Boston Harbor.

Boston, MA -- September 13 2026: Women's HealthX is pleased to welcome medical technology giant Boston Scientific as an Platinum Sponsor. As provider networks and hospital networks across the United States battle severe margin compression and escalating technical claims denials, the ability to optimize clinical throughput has become a vital operational imperative.

Boston, MA -- September 10 2026: Women's HealthX is pleased to welcome Chisom Obiora, Head of People and Culture, North America at Sanofi, to the speaker faculty for this year's cross-functional forum in Boston. As enterprise organizations face mounting pressure...

Boston, MA -- September 11 2026: It has now been nearly a year since the U.S. Food and Drug Administration (FDA) finalized its long-awaited framework on Real-World Evidence (RWE) in December 2025. This directive, which was further sharpened through targeted enforcement updates...

Boston MA - September 8: The financial and operational baseline for U.S. acute-care hospitals shifted permanently this August. In a decisive structural directive, the Centers for Medicare & Medicaid Services (CMS) finalized its Fiscal Year 2027 Inpatient Prospective Payment System (IPPS) rule. The financial and operational baseline for U.S. acute-care hospitals shifted permanently this August. In a decisive structural directive, the Centers for Medicare & Medicaid Services (CMS) finalized its Fiscal Year 2027 Inpatient Prospective Payment System (IPPS) rule.

Boston MA - September 7: The regulatory runway for U.S. drug development shifted permanently this month. In an historic move, the U.S. Food and Drug Administration (FDA) granted accelerated approval to AstraZeneca's advanced breast cancer combination therapy, Etcamah (camizestrant). This decision marks the first time in global medical history...

Boston, MA -- September 4 2026: As you may remember, this summer, the U.S. Equal Employment Opportunity Commission (EEOC) finalized its new comprehensive enforcement guidelines. Most notably, this updated national framework officially codifies specialized accommodations for...

Boston, MA -- September 3 2026: As healthcare organizations continue to evaluate where to invest their time, budget, and attention, one question comes up repeatedly: Who will actually be in the room?

Boston, MA -- September 2 2026: Women's HealthX is pleased to welcome JBA Intelligence as a Start-Up Partner for this year's event in Boston.

As healthcare organizations face increasing pressure to improve access, efficiency, outcomes, and workforce sustainability, the ability to understand what is happening across day-to-day operations has never been more important.

Boston, MA -- Sept 1 2026: Employers have largely moved beyond asking whether maternity benefits matter. The more difficult question is: What do they actually deliver? For some organizations, the answer is improved employee wellbeing. For others, it's retention, attendance, productivity, and long-term workforce stability. Yet measuring those outcomes remains surprisingly difficult.

Boston, MA -- September 1 2026: Women's HealthX is pleased to welcome Heidi Health as an exhibitor for this year's event in Boston.

As healthcare organizations continue to grapple with workforce pressures, clinician burnout, and increasing administrative demands, Heidi Health is helping clinicians reclaim valuable time through AI-powered clinical documentation.

Gestational diabetes diagnoses in England rose by 60% between 2018 and 2022, with the condition now affecting more than one in eight pregnancies.

The findings highlight significant disparities and reinforce the need for stronger maternity care and long-term follow-up, as gestational diabetes is associated with adverse pregnancy outcomes and increased future cardiometabolic and cardiovascular risk.

Boston, MA -- August 25 2026: Maternal health technology continues to advance, but the challenge is not always whether new tools exist. Across maternity care, the way diagnostics are integrated into clinical workflows, connected across the care journey, and translated into action can determine how useful they are for healthcare professionals and patients.

Speaking ahead of Women's HealthX, Dr. Andrea Willis, SVP & Chief Medical Officer, Blue Cross Blue Shield Tennessee, Dr. Ndidiamaka Amutah-Onukagha, Julia A. Okoro Professor of Black Maternal Health, Director and Founder, Center for Maternal Health Advancement, Tufts University School of Medicine, and Dr. Katherine Arnold, Program Manager, ARPA-H, discuss which maternal health diagnostics are most in need of modernization and what is holding progress back.

Maternal health outcomes are often discussed through the lens of clinical interventions, diagnostics and treatment pathways. However, according to Dr. Ndidiamaka Amutah-Onukagha, many of the most significant challenges facing women occur not because solutions do not exist, but because healthcare systems struggle to deliver continuous, coordinated support across the maternity journey. Speaking ahead of Women's HealthX,

Boston, MA -- August 25 2026: Some of the most serious maternity risks can escalate quickly, yet their earliest signs may resemble common experiences during pregnancy or postpartum recovery. 

Speaking ahead of Women's HealthX, Dr. Andrea Willis, SVP & Chief Medical Officer, Blue Cross Blue Shield Tennessee, Dr. Kate Arnold, Program Manager, ARPA-H and Dr. Ndidiamaka Amutah-Onukagha, Julia A. Okoro Professor of Black Maternal Health Director and Founder, Center for Maternal Health Advancement, Tufts University School of Medicine, discuss why early risk identification remains challenging and what healthcare professionals and systems should prioritize.

Boston, MA -- August 25 2026: Pregnancy, childbirth, and postpartum recovery form a continuous healthcare journey. Yet the way care is delivered does not always reflect that continuity.

Speaking ahead of Women's HealthX, Dr. Andrea Willis, SVP & Chief Medical Officer, Blue Cross Blue Shield Tennessee, Dr. Kate Arnold, Program Manager, ARPA-H and Dr. Ndidiamaka Amutah-Onukagha, Julia A. Okoro Professor of Black Maternal Health Director and Founder, Center for Maternal Health Advancement, Tufts University School of Medicine, discuss why women continue to fall through gaps between primary care, maternity services, and postnatal care, and what healthcare professionals and systems should consider when strengthening continuity.

Boston, MA -- August 25 2026: Translating scientific evidence into consistent clinical practice remains a central challenge in maternal care. While evidence may already exist around practices that can improve outcomes, implementation can vary across workflows, institutions, and patient populations.

Speaking ahead of Women's HealthX, Dr. Ndidiamaka Amutah-Onukagha, Julia A. Okoro Professor of Black Maternal Health, Director and Founder, Center for Maternal Health Advancement, Tufts University School of Medicine, Dr. Katherine Arnold, Program Manager, ARPA-H, and Dr. Andrea Willis, SVP & Chief Medical Officer, Blue Cross Blue Shield Tennessee, discuss where the gap between scientific evidence and clinical practice persists and what healthcare leaders should consider when translating evidence into care.

Women's HealthX has officially confirmed Foravisét as exclusive Lead Research Partner for the upcoming 2026 U.S. Women's Health Infrastructure Report. Find out more about what they will do for it and for Women's HeathX this December.

Women's HealthX is delighted to announce Fuze Health as a Diamond Sponsor of Women's HealthX 2026, taking place December 3-4 at Encore Boston Harbor.

Wouldn't it be great to get a snapshot of what your peers, partners and counterparties thoughts are on some of 2026's most compelling topics across the U.S. healthcare system? Read on...

Women's health has been held back by siloed ways of working, limited women's data, discussions that focus on challenges without presenting solutions, and conferences that fail to create meaningful connections. That's exactly what we're changing at Women's HealthX.

We've created a platform that brings the entire women's health ecosystem together to share evidence-based insights, showcase innovative solutions, foster collaboration, and build the partnerships needed to drive real progress across women's health.

Here are 5 reasons you should attend, according to Joanna Magaji, Senior Conference Producer of Women's HealthX.

Read the full blog to find out more.

Two innovative endometriosis tests, EndoSure and Endotest, have been recommended by NICE for temporary NHS use in England and Wales, offering the potential to significantly reduce the average nine-year wait for diagnosis.

The non-invasive technologies aim to help identify endometriosis earlier, enabling faster treatment and reducing the need for diagnostic surgery.

The tests will be used for three years while further evidence is gathered, marking an important step toward improving outcomes for the millions of women affected by the condition.

With thanks to our media partner, FemTech World, for providing this article.

New research suggests that women with PMOS (previously known as PCOS) may face a fourfold higher risk of heart disease, even after accounting for other cardiovascular risk factors.

The findings highlight the importance of earlier diagnosis, routine cardiovascular screening, and greater awareness among both healthcare professionals and patients to help reduce long-term health risks.

Researchers are also calling for further studies into how treatments such as GLP-1 medications and hormonal contraception may influence cardiovascular outcomes in women with PMOS.

With thanks to our media partner, FemTech World, for providing this article.

To mark Endometriosis Awareness Month, Women’s HealthX is excited to announce that Padma Lakshmi will join the event as a keynote speaker, bringing one of the most influential voices in women’s health advocacy to the stage.

Boston, March 30 2026 - New York Times bestselling author and Emmy nominated host and executive producer of Hulu’s Taste the Nation, Padma Lakshmi, is widely recognized for her impact across media, culture, and advocacy. Named one of Time Magazine’s 100 Most Influential People in 2023, she has become a leading voice in women’s health through her advocacy on endometriosis.

Having spoken openly about her own experience with the condition, Lakshmi has helped raise awareness of delayed diagnosis, chronic pain, and systemic gaps in care. As Co-Founder of the Endometriosis Foundation of America, she has played a key role in advancing education, research, and policy attention for a disease that affects millions globally.

At Women’s HealthX, Lakshmi will headline a fireside chat titled The Invisible Disease: What Endometriosis Reveals About the Future of Women’s Health. Endometriosis remains widely misunderstood, underfunded, and frequently diagnosed years too late. Using the condition as a case study, the session will explore broader systemic challenges across women’s health, from research inequities to clinical blind spots.

February 25, 2026, Boston — Women's HealthX (WoHX) is the number one event in women's health, unifying the full lifecycle of female healthcare through data, science, and evidence-based innovation to close the sex difference data gap and drive better clinical outcomes for women worldwide.

On December 3–4, 2026 in Boston, WoHX will bring together 750 global leaders from pharma and biotech, hospitals and health systems, health insurers, employers, investors, startups, and government, all actively seeking proven technologies, data, and partners to advance women's health care, research, and outcomes across the life course.

Unlike any other event, WoHX goes beyond discussion to focus on implementation of representative data sets to drive meaningful change. The exhibition directly addresses the conditions that affect women differently and disproportionately, across every stage of life.